KEGG pathways enriched for interacted genes |
pathway name | pathway description | target genes enrich in pathway | p-value |
|
hsa04110
|
Cell cycle |
CCNA2,EP300,CCNB1,YWHAG,RB1,CDKN1A, |
2.66E-1 |
hsa05200
|
Pathways in cancer |
CRK,PTEN,WNT3A,FGF22,FOXO1,PTGS2,EP300,RB1,CDKN1A,PTCH1, |
3.18E-1 |
hsa05215
|
Prostate cancer |
PTEN,FOXO1,EP300,RB1,CDKN1A, |
3.19E-1 |
hsa05110
|
Vibrio cholerae infection |
CFTR,ATP6V0E1,SEC61A1,TJP1, |
3.97E-1 |
hsa04115
|
p53 signaling pathway |
PTEN,CCNB1,CDKN1A,THBS1, |
6.41E-1 |
|
hsa05218
|
Melanoma |
PTEN,FGF22,RB1,CDKN1A, |
7.11E-1 |
hsa04722
|
Neurotrophin signaling pathway |
CRK,FOXO3,MAP3K3,YWHAG,IRAK1, |
8.68E-1 |
|
|
|
|
|
|
Gene ontology terms enriched for interacted genes |
GO terms | GO terms description | target genes enrich in GO term | p-value |
|
GO:0048545
|
response to steroid hormone stimulus |
PTEN,GATA3,CCNA2,CFTR,PTGS2,BRCA1,EP300,CDKN1A,MMP13,MAP1B,PTCH1,THBS1, |
5.22E-6 |
GO:0043627
|
response to estrogen stimulus |
PTEN,GATA3,CCNA2,CFTR,PTGS2,BRCA1,MMP13,MAP1B,PTCH1, |
1.35E-5 |
GO:0009719
|
response to endogenous stimulus |
PTEN,GATA3,CFTR,CCNA2,FOXO1,EP300,PTGS2,BRCA1,CDKN1A,PTCH1,ATP6V0E1,MAP1B,MMP13,THBS1, |
3.15E-4 |
GO:0042493
|
response to drug |
CDH3,PTEN,CFTR,PTGS2,NBN,EP300,CDKN1A,MAP1B,PTCH1,ABCG2, |
4.32E-4 |
GO:0009725
|
response to hormone stimulus |
PTEN,CFTR,CCNA2,GATA3,FOXO1,EP300,PTGS2,BRCA1,CDKN1A,PTCH1,MAP1B,MMP13,THBS1, |
4.56E-4 |
|
GO:0032355
|
response to estradiol stimulus |
PTEN,CCNA2,PTGS2,MAP1B,PTCH1, |
2.38E-2 |
GO:0008219
|
cell death |
ECT2,PTEN,RTN4,CASP7,MEF2A,BRCA1,FOXO3,EP300,ARF6,BNIP2,LIG4,PEA15,SPAST,NCKAP1,SMN1,SIRT1,THBS1, |
3.33E-2 |
GO:0016265
|
death |
ECT2,PTEN,RTN4,CASP7,MEF2A,BRCA1,FOXO3,EP300,ARF6,BNIP2,LIG4,PEA15,SPAST,NCKAP1,SMN1,SIRT1,THBS1, |
3.57E-2 |
GO:0006915
|
apoptosis |
ECT2,PTEN,RTN4,CASP7,MEF2A,FOXO3,EP300,BRCA1,ARF6,BNIP2,LIG4,PEA15,NCKAP1,THBS1,SIRT1, |
4.08E-2 |
GO:0001953
|
negative regulation of cell-matrix adhesion |
PTEN,THBS1,RASA1, |
4.59E-2 |
GO:0012501
|
programmed cell death |
ECT2,PTEN,RTN4,CASP7,MEF2A,FOXO3,EP300,BRCA1,ARF6,BNIP2,LIG4,PEA15,NCKAP1,THBS1,SIRT1, |
4.65E-2 |
GO:0010812
|
negative regulation of cell-substrate adhesion |
PTEN,THBS1,RASA1, |
5.57E-2 |
GO:0048145
|
regulation of fibroblast proliferation |
CCNA2,NBN,CDKN1A,LIG4, |
5.68E-2 |
GO:0033554
|
cellular response to stress |
CCNA2,MDFIC,FOXO3,NBN,EYA4,BRCA1,PTPLAD1,CDKN1A,LIG4,GTF2H1,MAP1B,THBS1,SIRT1,POLK, |
6.21E-2 |
GO:0045767
|
regulation of anti-apoptosis |
RTN4,CDKN1A,SIRT1,RASA1, |
7.16E-2 |
GO:0032535
|
regulation of cellular component size |
RTN4,EP300,HBEGF,ATP6V0E1,RB1,ARF6,CDKN1A,MAP1B,RASA1, |
7.49E-2 |
GO:0031572
|
G2/M transition DNA damage checkpoint |
CCNA2,BRCA1,NBN, |
7.80E-2 |
GO:0042127
|
regulation of cell proliferation |
PTEN,CCNA2,FOXO1,BRCA1,NBN,PTGS2,NAP1L1,RB1,CD164,CDKN1A,PTCH1,LIG4,FOXP2,HBEGF,SIRT1,THBS1,FABP7, |
7.86E-2 |
GO:0010033
|
response to organic substance |
CHRNA5,PTEN,GATA3,CFTR,CCNA2,FOXO1,BRCA1,EP300,PTGS2,CDKN1A,PTCH1,ATP6V0E1,IRAK1,MMP13,MAP1B,THBS1, |
8.17E-2 |
GO:0030728
|
ovulation |
PTGS2,FOXO3,SIRT1, |
9.04E-2 |
GO:0007162
|
negative regulation of cell adhesion |
PTEN,CD164,THBS1,RASA1, |
1.00E-1 |
|
|
|
|
|
|